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Background: Gene therapeutic-delivered overexpression of P-
glycoprotein (P-gp), the product of MDR1 (multidrug resistance
1) gene, might protect normal tissue during chemo- and radio-
therapy of P-gp-expressing tumors. However, little is known
about the influence of MDR1-overexpression on the expression
of other genes.
Methods: Differentially gene expression in untransduced and
oncoretrovirally transduced human lymphoblastoid TK6 cells
were analysed by using the GeneChip Human Genome U133
Plus2.0 (Affymetrix). The expression of several genes was vali-
dated with quantitative real-time PCR (TaqMan; Applied Biosys-
tems). Radiation-induced apoptosis was analysed by the sub-G1
DNA content using flow cytometry. Cell survival was measured
by the colony formation assay.
Results: Sixty-one annotated genes showed a significant change
in expression (p < 104) in MDR1-overexpressing compared to
untransduced and control virus-transduced cells. Several genes
coding for proteins involved in detoxification and exocytosis (e.g.
ALDH1A, UNC13) were up-regulated. Additionally, proapoptotic
genes were down-regulated (e.g. CASP1, CASP4) with concomitant
increased expression of the potential antiapoptotic gene AKT3. In
functional assays overexpression of MDR1 conferred protection
against radiation-induced clonogenic inactivation and apoptosis.
Conclusion: The resistant phenotype of MDR1-mediated P-gp
overexpressing cells is associated with differential expression of
several genes coding for metabolic as well as pro- and antiapopto-
tic proteins. Our results could have important implications for
MDR1-gene therapy in patients receiving chemotherapy regimens
in combination with radiotherapy.
doi:10.1016/j.ejcsup.2006.04.079
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Background: BAFF, APRIL and TNFR-family members are involved
in various cancers including B cell malignancies. The aim of thestudy is to identify new therapeutic targets in multiple myeloma
using gene expression analysis.
Methods: Samples of 65 patients (CD138-purified myeloma cells
(MMC) and bone-marrow-microenvironment (BMME)), 7 normal
bone-marrow-plasma-cell-samples (BMPC), 7 in vitro generated
osteoclast-samples, and 20 human-myeloma-cell-lines were
investigated. The expression of TACI, BCMA and BAFFR and the
respective ligands BAFF and APRIL on MMC and BMSC was
assessed by quantitative RT-PCR and Affymetrix U133 A + B
DNA-microarrays. BMMAs of MM-patients were exposed to the
TACI-Fc5 fusion-protein (Serono) containing the extracellular
BAFF/APRIL-binding domain of TACI and the Fc-region of human
Immungobulin G, to neutralize BAFF and APRIL secreted by MMC/
BMME.
Results: MMC express TACI, the receptor of BAFF/APRIL. BAFF
and APRIL promote MMC growth. The main site of production
for BAFF and APRIL is the BMME, i.e. monocytes/neutrophils and
osteoclasts, respectively.1,2 The TACI-Fc5 fusion protein is cur-
rently under investigation in a clinical phase I/II trial at the Uni-
versity Hospitals of Montpellier and Heidelberg.
Conclusion: Inhibiting TACI-signaling via BAFF and APRIL by a
TACI-Fc5 fusion protein is a promising new therapeutic approach
in the treatment of MM.
doi:10.1016/j.ejcsup.2006.04.080
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Background: To test the ability of our EC-classification1,2 to (i)
predict EFS in 100 MM-patients treated with high-dose-chemo-
therapy and autologous-stem-cell-transplantation, (ii) investigate
whether the classification represents an independent prognostic
factor.
Methods: 128 newly-diagnosed MM-patients (65 training-group/
63 validation-group) were included. Bone-marrow aspirates
were CD138-purified and RNA subjected to Affymetrix HG
U133 A + B (training-group) and 2.0+ (validation-group) arrays.
CCND1-, CCND2- and FGFR3-expression were verified by RT-
PCR and Western-blotting. iFISH was performed for chromo-
somes 1q21, 11q23, 11q13, 13q14, 17p13, t(4;14) and t(11;14).
Expression data were gcrma-normalised and nearest-shrun-
ken-centroids applied to cross-validate a predictor on the train-
ing-group. Log-rank test and Cox-proportional-hazard-model
